Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
International Journal of Radiation Oncology, Biology, Physics|January 27, 2020
Lung Stereotactic Body Radiation Therapy and Concurrent Immunotherapy: A Multicenter Safety and Toxicity AnalysisSibo Tian, Jeffrey M Switchenko, Zachary S Buchwald, et al.
JAMA Network Open|October 13, 2025
Survival Determinants and Sociodemographic Disparities in Early-Onset Non-Small Cell Lung CancerIrem Kar, Farheen Vhora, Maroun Bou Zerdan, et al.
JAMA Oncology|December 16, 2016
Comparison of Concurrent Use of Thoracic Radiation With Either Carboplatin-Paclitaxel or Cisplatin-Etoposide for Patients With Stage III Non-Small-Cell Lung Cancer: A Systematic ReviewConor E Steuer, Madhusmita Behera, Vinicius Ernani, et al.
The Lancet. Oncology|July 29, 2019
Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trialDouglas Adkins, Jessica Ley, Prakash Neupane, et al.
The Oncologist|January 17, 2020
Trimodality Therapy in the Treatment of Stage III N2-Positive Non-Small Cell Lung Cancer: A National Cancer Database AnalysisMadhusmita Behera, Conor E Steuer, Yuan Liu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 4, 2021
Smoking Behavior in Patients With Early-Stage NSCLC: A Report From ECOG-ACRIN 1505 TrialConor E Steuer, Opeyemi A Jegede, Suzanne E Dahlberg, et al.
The Lancet. Oncology|June 27, 2024
Assessment of endpoint definitions in recurrent and metastatic mucosal head and neck squamous cell carcinoma trials: Head and Neck Cancer International Group consensus recommendationsAnnette M Lim, Christophe Le Tourneau, Chris Hurt, et al.
Clinical Lung Cancer|June 12, 2017
Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database AnalysisHiba Z Ahmed, Yuan Liu, Kelli O'Connell, et al.
Cancers|June 10, 2022
A Multicenter Randomized Phase II Study of Single Agent Efficacy and Optimal Combination Sequence of Everolimus and Pasireotide LAR in Advanced Thyroid CancerJulie E Bauman, Zhengjia Chen, Chao Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 23, 2022
Impact of radiation dose to the immune cells in unresectable or stage III non-small cell lung cancer in the durvalumab eraNeal S McCall, Hamilton S McGinnis, James R Janopaul-Naylor, et al.
Pageof 8